{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T01:50:07Z","timestamp":1792029007777,"version":"4.4.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T00:00:00Z","timestamp":1744243200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T00:00:00Z","timestamp":1744243200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Interleukin-1 (IL-1)\/IL-1 receptor family consists of activators and inhibitors which play a key role in inflammation, emergency myelopoiesis, and myeloid cell activation. The latter includes the IL-1R2 decoy receptor. To investigate the expression and significance of IL-1R2 in sepsis, we conducted high-dimensional flow cytometry of circulating cells from patients stratified according to the Sequential Sepsis-Related Organ Failure Assessment (SOFA) score. Here we report that the IL-1 decoy receptor is selectively upregulated on the plasma membrane of leukocytes and, in particular, monocytes from septic patients, and downregulated in septic shock. Flow cytometry combined with transcriptomic analysis of publicly available datasets indicated that IL-1R2 is associated with the differentiation of monocytes to a population of circulating monocytic cells with macrophage features (Mono\/M\n                    <jats:italic>\u03c6<\/jats:italic>\n                    ). In vitro stimulation of monocytes from healthy donors with Colony Stimulating Factors (CSFs), in particular GM-CSF and Lipopolysaccharides (LPS), induced IL-1R2\n                    <jats:sup>+<\/jats:sup>\n                    Mono\/M\n                    <jats:italic>\u03c6<\/jats:italic>\n                    , which recapitulated the characteristics of sepsis-associated monocytic cells, including low expression of HLA-DR, high levels of macrophage markers such as MS4A4A and CD63, immune checkpoints, immunosuppressive molecules and selected scavenger receptors. Membrane-associated IL-1R2 and MS4A4A correlated with immunological markers, cytokine storm, and clinical parameters (e.g., SOFA score, creatinine, survival), reflecting the infection severity in hospitalized patients.\n                  <\/jats:p>\n                  <jats:p>Thus, in sepsis IL-1R2 is expressed in a subset of circulating monocytes co-expressing mature macrophage and immune dysfunction features with clinical significance.<\/jats:p>","DOI":"10.1038\/s41419-025-07597-x","type":"journal-article","created":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T18:55:01Z","timestamp":1744224901000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Monocyte-macrophage membrane expression of IL-1R2 is a severity biomarker in sepsis"],"prefix":"10.1038","volume":"16","author":[{"given":"Domenico","family":"Supino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadaf","family":"Davoudian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Silva-Gomes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele","family":"Piovani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Garuti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Desai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah N.","family":"Mapelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Scavello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9176-5636","authenticated-orcid":false,"given":"Silvia","family":"Carnevale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Mariancini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Magrini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Leone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Sironi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Valentino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diletta","family":"Di Mitri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Portale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Fedeli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise","family":"Comina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6102-6579","authenticated-orcid":false,"given":"Stefanos","family":"Bonovas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Voza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5578-236X","authenticated-orcid":false,"given":"Alberto","family":"Mantovani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Bottazzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia","family":"Garlanda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,10]]},"reference":[{"key":"7597_CR1","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1001\/jama.2016.0287","volume":"315","author":"M Singer","year":"2016","unstructured":"Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). Jama. 2016;315:801\u201310.","journal-title":"Jama"},{"key":"7597_CR2","doi-asserted-by":"publisher","first-page":"e422","DOI":"10.1016\/S1473-3099(19)30567-5","volume":"19","author":"I Rubio","year":"2019","unstructured":"Rubio I, Osuchowski MF, Shankar-Hari M, Skirecki T, Winkler MS, Lachmann G, et al. Current gaps in sepsis immunology: new opportunities for translational research. Lancet Infect Dis. 2019;19:e422\u2013e36.","journal-title":"Lancet Infect Dis"},{"key":"7597_CR3","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/nri.2017.36","volume":"17","author":"T van der Poll","year":"2017","unstructured":"van der Poll T, van de Veerdonk FL, Scicluna BP, Netea MG. The immunopathology of sepsis and potential therapeutic targets. Nat Rev Immunol. 2017;17:407\u201320.","journal-title":"Nat Rev Immunol"},{"key":"7597_CR4","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/S0140-6736(18)30696-2","volume":"392","author":"M Cecconi","year":"2018","unstructured":"Cecconi M, Evans L, Levy M, Rhodes A. Sepsis and septic shock. Lancet. 2018;392:75\u201387.","journal-title":"Lancet"},{"key":"7597_CR5","doi-asserted-by":"publisher","first-page":"2450","DOI":"10.1016\/j.immuni.2021.10.012","volume":"54","author":"T van der Poll","year":"2021","unstructured":"van der Poll T, Shankar-Hari M, Wiersinga WJ. The immunology of sepsis. Immunity. 2021;54:2450\u201364.","journal-title":"Immunity"},{"key":"7597_CR6","doi-asserted-by":"publisher","first-page":"104363","DOI":"10.1016\/j.ebiom.2022.104363","volume":"86","author":"WJ Wiersinga","year":"2022","unstructured":"Wiersinga WJ, van der Poll T. Immunopathophysiology of human sepsis. EBioMedicine. 2022;86:104363.","journal-title":"EBioMedicine"},{"key":"7597_CR7","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1016\/j.immuni.2019.03.012","volume":"50","author":"A Mantovani","year":"2019","unstructured":"Mantovani A, Dinarello CA, Molgora M, Garlanda C. Interleukin-1 and related cytokines in the regulation of inflammation and immunity. Immunity. 2019;50:778\u201395.","journal-title":"Immunity"},{"key":"7597_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.804641","volume":"13","author":"D Supino","year":"2022","unstructured":"Supino D, Minute L, Mariancini A, Riva F, Magrini E, Garlanda C. Negative regulation of the IL-1 system by IL-1R2 and IL-1R8: relevance in pathophysiology and disease. Front Immunol. 2022;13:804641.","journal-title":"Front Immunol"},{"key":"7597_CR9","doi-asserted-by":"publisher","first-page":"18951","DOI":"10.1073\/pnas.2009017117","volume":"117","author":"R Cauchois","year":"2020","unstructured":"Cauchois R, Koubi M, Delarbre D, Manet C, Carvelli J, Blasco VB, et al. Early IL-1 receptor blockade in severe inflammatory respiratory failure complicating COVID-19. Proc Natl Acad Sci USA. 2020;117:18951\u20133.","journal-title":"Proc Natl Acad Sci USA"},{"key":"7597_CR10","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1097\/CCM.0000000000001402","volume":"44","author":"B Shakoory","year":"2016","unstructured":"Shakoory B, Carcillo JA, Chatham WW, Amdur RL, Zhao H, Dinarello CA, et al. Interleukin-1 receptor blockade is associated with reduced mortality in sepsis patients with features of macrophage activation syndrome: reanalysis of a prior phase III trial. Crit Care Med. 2016;44:275\u201381.","journal-title":"Crit Care Med"},{"key":"7597_CR11","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/s41590-023-01660-5","volume":"25","author":"EJ Giamarellos-Bourboulis","year":"2024","unstructured":"Giamarellos-Bourboulis EJ, Aschenbrenner AC, Bauer M, Bock C, Calandra T, Gat-Viks I, et al. The pathophysiology of sepsis and precision-medicine-based immunotherapy. Nat Immunol. 2024;25:19\u201328.","journal-title":"Nat Immunol"},{"key":"7597_CR12","doi-asserted-by":"publisher","first-page":"979232","DOI":"10.3389\/fimmu.2022.979232","volume":"13","author":"S Davoudian","year":"2022","unstructured":"Davoudian S, Piovani D, Desai A, Mapelli SN, Leone R, Sironi M, et al. A cytokine\/PTX3 prognostic index as a predictor of mortality in sepsis. Front Immunol. 2022;13:979232.","journal-title":"Front Immunol"},{"key":"7597_CR13","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/s41591-020-0752-4","volume":"26","author":"M Reyes","year":"2020","unstructured":"Reyes M, Filbin MR, Bhattacharyya RP, Billman K, Eisenhaure T, Hung DT, et al. An immune-cell signature of bacterial sepsis. Nat Med. 2020;26:333\u201340.","journal-title":"Nat Med"},{"key":"7597_CR14","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1038\/s41590-023-01490-5","volume":"24","author":"AJ Kwok","year":"2023","unstructured":"Kwok AJ, Allcock A, Ferreira RC, Cano-Gamez E, Smee M, Burnham KL, et al. Neutrophils and emergency granulopoiesis drive immune suppression and an extreme response endotype during sepsis. Nat Immunol. 2023;24:767\u201379.","journal-title":"Nat Immunol"},{"key":"7597_CR15","doi-asserted-by":"publisher","first-page":"2432","DOI":"10.4049\/jimmunol.1000486","volume":"185","author":"DA Drevets","year":"2010","unstructured":"Drevets DA, Schawang JE, Mandava VK, Dillon MJ, Leenen PJ. Severe Listeria monocytogenes infection induces development of monocytes with distinct phenotypic and functional features. J Immunol. 2010;185:2432\u201341.","journal-title":"J Immunol"},{"key":"7597_CR16","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1159\/000443663","volume":"8","author":"C Giai","year":"2016","unstructured":"Giai C, Gonzalez CD, Sabbione F, Garofalo A, Ojeda D, Sordelli DO, et al. Staphylococcus aureus induces shedding of IL-1RII in monocytes and neutrophils. J Innate Immun. 2016;8:284\u201398.","journal-title":"J Innate Immun"},{"key":"7597_CR17","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1177\/096228029500400302","volume":"4","author":"T Hastie","year":"1995","unstructured":"Hastie T, Tibshirani R. Generalized additive models for medical research. Stat Methods Med Res. 1995;4:187\u201396.","journal-title":"Stat Methods Med Res"},{"key":"7597_CR18","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.immuni.2018.10.005","volume":"49","author":"M Guilliams","year":"2018","unstructured":"Guilliams M, Mildner A, Yona S. Developmental and functional heterogeneity of monocytes. Immunity. 2018;49:595\u2013613.","journal-title":"Immunity"},{"key":"7597_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-020-2830-x","volume":"24","author":"GP Leijte","year":"2020","unstructured":"Leijte GP, Rimmele T, Kox M, Bruse N, Monard C, Gossez M, et al. Monocytic HLA-DR expression kinetics in septic shock patients with different pathogens, sites of infection and adverse outcomes. Crit Care. 2020;24:110.","journal-title":"Crit Care"},{"key":"7597_CR20","doi-asserted-by":"publisher","first-page":"e0182427","DOI":"10.1371\/journal.pone.0182427","volume":"12","author":"MS Winkler","year":"2017","unstructured":"Winkler MS, Rissiek A, Priefler M, Schwedhelm E, Robbe L, Bauer A, et al. Human leucocyte antigen (HLA-DR) gene expression is reduced in sepsis and correlates with impaired TNFalpha response: a diagnostic tool for immunosuppression?. PLoS ONE. 2017;12:e0182427.","journal-title":"PLoS ONE"},{"key":"7597_CR21","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1038\/s41590-019-0417-y","volume":"20","author":"I Mattiola","year":"2019","unstructured":"Mattiola I, Tomay F, De Pizzol M, Silva-Gomes R, Savino B, Gulic T, et al. The macrophage tetraspan MS4A4A enhances dectin-1-dependent NK cell-mediated resistance to metastasis. Nat Immunol. 2019;20:1012\u201322.","journal-title":"Nat Immunol"},{"key":"7597_CR22","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1002\/JLB.2A0421-200R","volume":"111","author":"R Silva-Gomes","year":"2022","unstructured":"Silva-Gomes R, Mapelli SN, Boutet MA, Mattiola I, Sironi M, Grizzi F, et al. Differential expression and regulation of MS4A family members in myeloid cells in physiological and pathological conditions. J Leukoc Biol. 2022;111:817\u201336.","journal-title":"J Leukoc Biol"},{"key":"7597_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2020.108626","volume":"34","author":"S Daemen","year":"2021","unstructured":"Daemen S, Gainullina A, Kalugotla G, He L, Chan MM, Beals JW, et al. Dynamic shifts in the composition of resident and recruited macrophages influence tissue remodeling in NASH. Cell Rep. 2021;34:108626.","journal-title":"Cell Rep."},{"key":"7597_CR24","doi-asserted-by":"publisher","first-page":"7303","DOI":"10.4049\/jimmunol.177.10.7303","volume":"177","author":"FO Martinez","year":"2006","unstructured":"Martinez FO, Gordon S, Locati M, Mantovani A. Transcriptional profiling of the human monocyte-to-macrophage differentiation and polarization: new molecules and patterns of gene expression. J Immunol. 2006;177:7303\u201311.","journal-title":"J Immunol"},{"key":"7597_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-99777-w","volume":"11","author":"Y Im","year":"2021","unstructured":"Im Y, Yoo H, Ko RE, Lee JY, Park J, Jeon K. Exosomal CD63 in critically ill patients with sepsis. Sci Rep. 2021;11:20300.","journal-title":"Sci Rep"},{"key":"7597_CR26","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s13578-023-00990-z","volume":"13","author":"H Xiang","year":"2023","unstructured":"Xiang H, Xu Z, Zhang C, Xiong J. Macrophage-derived exosomes mediate glomerular endothelial cell dysfunction in sepsis-associated acute kidney injury. Cell Biosci. 2023;13:46.","journal-title":"Cell Biosci"},{"key":"7597_CR27","first-page":"2749","volume":"12","author":"J Lu","year":"2020","unstructured":"Lu J, Li Q, Wu Z, Zhong Z, Ji P, Li H, et al. Two gene set variation indexes as potential diagnostic tool for sepsis. Am J Transl Res. 2020;12:2749\u201359.","journal-title":"Am J Transl Res"},{"key":"7597_CR28","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/j.immuni.2010.05.007","volume":"32","author":"S Gordon","year":"2010","unstructured":"Gordon S, Martinez FO. Alternative activation of macrophages: mechanism and functions. Immunity. 2010;32:593\u2013604.","journal-title":"Immunity"},{"key":"7597_CR29","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1165\/rcmb.2015-0012OC","volume":"53","author":"AA Tarique","year":"2015","unstructured":"Tarique AA, Logan J, Thomas E, Holt PG, Sly PD, Fantino E. Phenotypic, functional, and plasticity features of classical and alternatively activated human macrophages. Am J Respir Cell Mol Biol. 2015;53:676\u201388.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"7597_CR30","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.3389\/fimmu.2018.01015","volume":"9","author":"BG Chousterman","year":"2018","unstructured":"Chousterman BG, Arnaud M. Is there a role for hematopoietic growth factors during sepsis? Front Immunol. 2018;9:1015.","journal-title":"Front Immunol"},{"key":"7597_CR31","doi-asserted-by":"publisher","first-page":"2931","DOI":"10.4049\/jimmunol.162.5.2931","volume":"162","author":"G Penton-Rol","year":"1999","unstructured":"Penton-Rol G, Orlando S, Polentarutti N, Bernasconi S, Muzio M, Introna M, et al. Bacterial lipopolysaccharide causes rapid shedding, followed by inhibition of mRNA expression of the IL-1 type II receptor, with concomitant up-regulation of the type I receptor and induction of incompletely spliced transcripts. J Immunol. 1999;162:2931\u20138.","journal-title":"J Immunol"},{"key":"7597_CR32","doi-asserted-by":"publisher","first-page":"2534","DOI":"10.4049\/jimmunol.156.7.2534","volume":"156","author":"F Colotta","year":"1996","unstructured":"Colotta F, Saccani S, Giri JG, Dower SK, Sims JE, Introna M, et al. Regulated expression and release of the IL-1 decoy receptor in human mononuclear phagocytes. J Immunol. 1996;156:2534\u201341.","journal-title":"J Immunol"},{"key":"7597_CR33","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1084\/jem.179.2.739","volume":"179","author":"F Re","year":"1994","unstructured":"Re F, Muzio M, De Rossi M, Polentarutti N, Giri JG, Mantovani A, et al. The type II \u201creceptor\u201d as a decoy target for interleukin 1 in polymorphonuclear leukocytes: characterization of induction by dexamethasone and ligand binding properties of the released decoy receptor. J Exp Med. 1994;179:739\u201343.","journal-title":"J Exp Med"},{"key":"7597_CR34","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1007\/s00281-017-0639-8","volume":"39","author":"BG Chousterman","year":"2017","unstructured":"Chousterman BG, Swirski FK, Weber GF. Cytokine storm and sepsis disease pathogenesis. Semin Immunopathol. 2017;39:517\u201328.","journal-title":"Semin Immunopathol"},{"key":"7597_CR35","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1189\/jlb.72.4.643","volume":"72","author":"B Muller","year":"2002","unstructured":"Muller B, Peri G, Doni A, Perruchoud AP, Landmann R, Pasqualini F, et al. High circulating levels of the IL-1 type II decoy receptor in critically ill patients with sepsis: association of high decoy receptor levels with glucocorticoid administration. J Leukoc Biol. 2002;72:643\u20139.","journal-title":"J Leukoc Biol"},{"key":"7597_CR36","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1093\/infdis\/175.1.118","volume":"175","author":"T van der Poll","year":"1997","unstructured":"van der Poll T, de Waal Malefyt R, Coyle SM, Lowry SF. Antiinflammatory cytokine responses during clinical sepsis and experimental endotoxemia: sequential measurements of plasma soluble interleukin (IL)-1 receptor type II, IL-10, and IL-13. J Infect Dis. 1997;175:118\u201322.","journal-title":"J Infect Dis"},{"key":"7597_CR37","first-page":"3282","volume":"87","author":"JH Pruitt","year":"1996","unstructured":"Pruitt JH, Welborn MB, Edwards PD, Harward TR, Seeger JW, Martin TD, et al. Increased soluble interleukin-1 type II receptor concentrations in postoperative patients and in patients with sepsis syndrome. Blood. 1996;87:3282\u20138.","journal-title":"Blood"},{"key":"7597_CR38","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1097\/00024382-199504000-00001","volume":"3","author":"JH Pruitt","year":"1995","unstructured":"Pruitt JH, Copeland EM 3rd, Moldawer LL. Interleukin-1 and interleukin-1 antagonism in sepsis, systemic inflammatory response syndrome, and septic shock. Shock. 1995;3:235\u201351.","journal-title":"Shock"},{"key":"7597_CR39","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.3389\/fimmu.2020.01426","volume":"11","author":"P Italiani","year":"2020","unstructured":"Italiani P, Mosca E, Della Camera G, Melillo D, Migliorini P, Milanesi L, et al. Profiling the course of resolving vs. persistent inflammation in human monocytes: the role of IL-1 family molecules. Front Immunol. 2020;11:1426.","journal-title":"Front Immunol"},{"key":"7597_CR40","doi-asserted-by":"publisher","first-page":"eabe9599","DOI":"10.1126\/scitranslmed.abe9599","volume":"13","author":"M Reyes","year":"2021","unstructured":"Reyes M, Filbin MR, Bhattacharyya RP, Sonny A, Mehta A, Billman K, et al. Plasma from patients with bacterial sepsis or severe COVID-19 induces suppressive myeloid cell production from hematopoietic progenitors in vitro. Sci Transl Med. 2021;13:eabe9599.","journal-title":"Sci Transl Med"},{"key":"7597_CR41","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/s41421-020-00225-2","volume":"6","author":"G Xu","year":"2020","unstructured":"Xu G, Qi F, Li H, Yang Q, Wang H, Wang X, et al. The differential immune responses to COVID-19 in peripheral and lung revealed by single-cell RNA sequencing. Cell Discov. 2020;6:73.","journal-title":"Cell Discov"},{"key":"7597_CR42","doi-asserted-by":"publisher","first-page":"587","DOI":"10.2478\/s11658-009-0023-3","volume":"14","author":"W Zhong","year":"2009","unstructured":"Zhong W, Fei M, Zhu Y, Zhang X. Transcriptional profiles during the differentiation and maturation of monocyte-derived dendritic cells, analyzed using focused microarrays. Cell Mol Biol Lett. 2009;14:587\u2013608.","journal-title":"Cell Mol Biol Lett"},{"key":"7597_CR43","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.immuni.2013.01.008","volume":"38","author":"Y Zheng","year":"2013","unstructured":"Zheng Y, Humphry M, Maguire JJ, Bennett MR, Clarke MC. Intracellular interleukin-1 receptor 2 binding prevents cleavage and activity of interleukin-1alpha, controlling necrosis-induced sterile inflammation. Immunity. 2013;38:285\u201395.","journal-title":"Immunity"},{"key":"7597_CR44","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1111\/sji.12162","volume":"79","author":"S Mia","year":"2014","unstructured":"Mia S, Warnecke A, Zhang XM, Malmstrom V, Harris RA. An optimized protocol for human M2 macrophages using M-CSF and IL-4\/IL-10\/TGF-beta yields a dominant immunosuppressive phenotype. Scand J Immunol. 2014;79:305\u201314.","journal-title":"Scand J Immunol"},{"key":"7597_CR45","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.immuni.2014.06.008","volume":"41","author":"PJ Murray","year":"2014","unstructured":"Murray PJ, Allen JE, Biswas SK, Fisher EA, Gilroy DW, Goerdt S, et al. Macrophage activation and polarization: nomenclature and experimental guidelines. Immunity. 2014;41:14\u201320.","journal-title":"Immunity"},{"key":"7597_CR46","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1007\/s00134-002-1335-1","volume":"28","author":"SE Perry","year":"2002","unstructured":"Perry SE, Mostafa SM, Wenstone R, McLaughlin PJ. Low plasma granulocyte-macrophage colony stimulating factor is an indicator of poor prognosis in sepsis. Intensive Care Med. 2002;28:981\u20134.","journal-title":"Intensive Care Med"},{"key":"7597_CR47","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1111\/j.1365-2249.1995.tb03844.x","volume":"102","author":"PM Waring","year":"1995","unstructured":"Waring PM, Presneill J, Maher DW, Layton JE, Cebon J, Waring LJ, et al. Differential alterations in plasma colony-stimulating factor concentrations in meningococcaemia. Clin Exp Immunol. 1995;102:501\u20136.","journal-title":"Clin Exp Immunol"},{"key":"7597_CR48","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/S0002-9343(97)00136-8","volume":"103","author":"B Francois","year":"1997","unstructured":"Francois B, Trimoreau F, Vignon P, Fixe P, Praloran V, Gastinne H. Thrombocytopenia in the sepsis syndrome: role of hemophagocytosis and macrophage colony-stimulating factor. Am J Med. 1997;103:114\u201320.","journal-title":"Am J Med"},{"key":"7597_CR49","doi-asserted-by":"publisher","first-page":"2057","DOI":"10.1038\/s41423-021-00719-3","volume":"18","author":"X Mu","year":"2021","unstructured":"Mu X, Liu K, Li H, Wang FS, Xu R. Granulocyte-macrophage colony-stimulating factor: an immunotarget for sepsis and COVID-19. Cell Mol Immunol. 2021;18:2057\u20138.","journal-title":"Cell Mol Immunol"},{"key":"7597_CR50","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcrc.2023.154330","volume":"78","author":"CH Vacheron","year":"2023","unstructured":"Vacheron CH, Lepape A, Venet F, Monneret G, Gueyffier F, Boutitie F, et al. Granulocyte-macrophage colony-stimulating factor (GM-CSF) in patients presenting sepsis-induced immunosuppression: the GRID randomized controlled trial. J Crit Care. 2023;78:154330.","journal-title":"J Crit Care"},{"key":"7597_CR51","first-page":"2746","volume":"37","author":"AC Lukaszewicz","year":"2009","unstructured":"Lukaszewicz AC, Grienay M, Resche-Rigon M, Pirracchio R, Faivre V, Boval B, et al. Monocytic HLA-DR expression in intensive care patients: interest for prognosis and secondary infection prediction. Crit Care Med. 2009;37:2746\u201352.","journal-title":"Crit Care Med"},{"key":"7597_CR52","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-35932-0","volume":"8","author":"M Gossez","year":"2018","unstructured":"Gossez M, Rimmele T, Andrieu T, Debord S, Bayle F, Malcus C, et al. Proof of concept study of mass cytometry in septic shock patients reveals novel immune alterations. Sci Rep. 2018;8:17296.","journal-title":"Sci Rep"},{"key":"7597_CR53","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1007\/s00134-018-5247-0","volume":"44","author":"A Conway Morris","year":"2018","unstructured":"Conway Morris A, Datta D, Shankar-Hari M, Stephen J, Weir CJ, Rennie J, et al. Cell-surface signatures of immune dysfunction risk-stratify critically ill patients: INFECT study. Intensive Care Med. 2018;44:627\u201335.","journal-title":"Intensive Care Med"},{"key":"7597_CR54","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.immuni.2019.01.019","volume":"50","author":"JL Schultze","year":"2019","unstructured":"Schultze JL, Mass E, Schlitzer A. Emerging principles in myelopoiesis at homeostasis and during infection and inflammation. Immunity. 2019;50:288\u2013301.","journal-title":"Immunity"},{"key":"7597_CR55","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms12150","volume":"7","author":"V Bronte","year":"2016","unstructured":"Bronte V, Brandau S, Chen SH, Colombo MP, Frey AB, Greten TF, et al. Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards. Nat Commun. 2016;7:12150.","journal-title":"Nat Commun"},{"key":"7597_CR56","doi-asserted-by":"publisher","first-page":"183","DOI":"10.3389\/fimmu.2019.00183","volume":"10","author":"MY Park","year":"2019","unstructured":"Park MY, Lim BG, Kim SY, Sohn HJ, Kim S, Kim TG. GM-CSF promotes the expansion and differentiation of cord blood myeloid-derived suppressor cells, which attenuate xenogeneic graft vs.-host disease. Front Immunol. 2019;10:183.","journal-title":"Front Immunol"},{"key":"7597_CR57","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1002\/eji.202048585","volume":"50","author":"Y Sui","year":"2020","unstructured":"Sui Y, Zeng W. MS4A4A regulates arginase 1 induction during macrophage polarization and lung inflammation in mice. Eur J Immunol. 2020;50:1602\u20135.","journal-title":"Eur J Immunol"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07597-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07597-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07597-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T20:03:22Z","timestamp":1744229002000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07597-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,10]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["7597"],"URL":"https:\/\/doi.org\/10.1038\/s41419-025-07597-x","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,10]]},"assertion":[{"value":"11 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study complied with the provisions of the Declaration of Helsinki and was approved by the Institutional Review Board of Humanitas Research Hospital (Approval n\u00b0 820\/18). Patients were enrolled only after the signature of a written informed consent. In this case, the patient was unable to provide consent, this was obtained from their relatives. Confidentiality of patient data was preserved, and no patient identifiers were used in the dataset.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and Consent for publication"}}],"article-number":"269"}}